| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10799869 | Biochimica et Biophysica Acta (BBA) - General Subjects | 2016 | 8 Pages |
Abstract
General significance: Glutamine (gln)-modified analogues of xenin may represent an attractive therapeutic approach for type 2 diabetes.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Vadivel Parthsarathy, Nigel Irwin, Annie Hasib, Christine M. Martin, Stephen McClean, Vikas K. Bhat, Ming T. Ng, Peter R. Flatt, Victor A. Gault,